Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Pharmacokinetics of raloxifene in male Wistar-Hannover rats: Influence of complexation with hydroxybutenyl-beta-cyclodextrin.

Pharmacokinetics of raloxifene in male Wistar-Hannover rats: Influence of complexation with hydroxybutenyl-beta-cyclodextrin. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Pharmacokinetics of raloxifene in male Wistar-Hannover rats: Influence of complexation with hydroxybutenyl-beta-cyclodextrin. Abstract Text:

    michael f wempeMichael F Wempe,vincent j wacherVincent J Wacher,karen m rubleKaren M Ruble,michael g ramseyMichael G Ramsey,kevin j edgarKevin J Edgar,norma l buchananNorma L Buchanan,charles m buchananCharles M Buchanan,michael f wempeMichael F Wempe,vincent j wacherVincent J Wacher,karen m rubleKaren M Ruble,michael g ramseyMichael G Ramsey,kevin j edgarKevin J Edgar,norma l buchananNorma L Buchanan,charles m buchananCharles M Buchanan,michael f wempeMichael F Wempe,vincent j wacherVincent J Wacher,karen m rubleKaren M Ruble,michael g ramseyMichael G Ramsey,kevin j edgarKevin J Edgar,norma l buchananNorma L Buchanan,charles m buchananCharles M Buchanan,

    Raloxifene is a highly insoluble, highly metabolized serum estrogen receptor modulator approved for use in the treatment of osteoporosis. Hydroxybutenyl-beta-cyclodextrin (HBenBCD) is a novel solubility enhancer previously demonstrated to increase the oral bioavailability of tamoxifen, letrozole, and itraconazole. The current study evaluated the pharmacokinetics of raloxifene in oral and intravenous formulations with HBenBCD in male Wistar-Hannover rats. Analytical methodology to measure raloxifene and its metabolites was developed by measuring raloxifene metabolism in vitro. Formulation with HBenBCD significantly increased raloxifene oral bioavailability. Mean+/-S.D. oral bioavailabilities were 2.6+/-0.4% for raloxifene formulated with microcrystalline cellulose, 7.7+/-2.1% for a solid capsule formulation of raloxifene:HBenBCD complex, and 5.7+/-1.3% for a liquid-filled capsule formulation containing raloxifene:HBenBCD/PEG400/H(2)O. Relative to raloxifene/microcrystalline filled capsules, the presence of HBenBCD in the solid capsule formulation afforded: (i) a decrease in raloxifene T(max) (2.5+/-0.5h versus 4.0+/-0.5h); (ii) a two-fold increase in raloxifene C(max) and a three-fold increase in raloxifene AUC; and (iii) a 12-fold increase in raloxifene glucuronide C(max) and a 6.5-fold increase in raloxifene glucuronide AUC. Hence, these studies demonstrate that raloxifene formulations containing HBenBCD significantly increased the oral bioavailability in rats relative to formulations that did not contain HBenBCD.

    Pharmacokinetics of raloxifene in male Wistar-Hannover rats: Influence of complexation with hydroxybutenyl-beta-cyclodextrin. Publishing Authors By Initials

    mf wempeMF Wempe,vj wacherVJ Wacher,km rubleKM Ruble,mg ramseyMG Ramsey,kj edgarKJ Edgar,nl buchananNL Buchanan,cm buchananCM Buchanan,mf wempeMF Wempe,vj wacherVJ Wacher,km rubleKM Ruble,mg ramseyMG Ramsey,kj edgarKJ Edgar,nl buchananNL Buchanan,cm buchananCM Buchanan,mf wempeMF Wempe,vj wacherVJ Wacher,km rubleKM Ruble,mg ramseyMG Ramsey,kj edgarKJ Edgar,nl buchananNL Buchanan,cm buchananCM Buchanan,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Pharmacokinetics of raloxifene in male Wistar-Hannover rats: Influence of complexation with hydroxybutenyl-beta-cyclodextrin. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: International journal of pharmaceutics

    VOLUME: 346

    Page Numbers: 25-37

    Journal Abbreviation:

    ISSN: 0378-5173

    DAY: 12

    MONTH: 06

    YEAR: 2007

    Pharmacokinetics of raloxifene in male Wistar-Hannover rats: Influence of complexation with hydroxybutenyl-beta-cyclodextrin. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7804127

    Pharmacokinetics of raloxifene in male Wistar-Hannover rats: Influence of complexation with hydroxybutenyl-beta-cyclodextrin. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Pharmacokinetics of raloxifene in male Wistar-Hannover rats: Influence of complexation with hydroxybutenyl-beta-cyclodextrin. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Pharmacokinetics of raloxifene in male Wistar-Hannover rats: Influence of complexation with hydroxybutenyl-beta-cyclodextrin.

    AFFILIATION: Eastman Chemical Company, Kingsport, TN, USA; Department of Pharmacology, East Tennessee State University, Johnson City, TN, USA.

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Int J Pharm

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Pharmacokinetics of raloxifene in male Wistar-Hannover rats: Influence of complexation with hydroxybutenyl-beta-cyclodextrin Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News